Novonesis (Novozymes) B (WBO:NZYM) EV-to-Revenue : 7.46 (As of Jun. 02, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Novonesis (Novozymes) B EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Novonesis (Novozymes) B's enterprise value is €30,275 Mil. Novonesis (Novozymes) B's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €4,058 Mil. Therefore, Novonesis (Novozymes) B's EV-to-Revenue for today is 7.46.

The historical rank and industry rank for Novonesis (Novozymes) B's EV-to-Revenue or its related term are showing as below:

WBO:NZYM' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.39 Med: 6.59 Max: 10.29
Current: 7.46

During the past 13 years, the highest EV-to-Revenue of Novonesis (Novozymes) B was 10.29. The lowest was 4.39. And the median was 6.59.

WBO:NZYM's EV-to-Revenue is ranked worse than
91.19% of 1543 companies
in the Chemicals industry
Industry Median: 1.55 vs WBO:NZYM: 7.46

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Novonesis (Novozymes) B's stock price is €62.44. Novonesis (Novozymes) B's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €8.66. Therefore, Novonesis (Novozymes) B's PS Ratio for today is 7.21.

Novonesis (Novozymes) B EV-to-Revenue Historical Data

The historical data trend for Novonesis (Novozymes) B's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B EV-to-Revenue Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

6.91

10.08

5.90

6.14

7.04

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															6.14	7.81	7.76	7.04	6.53

Competitive Comparison of Novonesis (Novozymes) B's EV-to-Revenue

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's EV-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Novonesis (Novozymes) B EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Novonesis (Novozymes) B's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	30274.700	/	4057.6
	=	7.46

Novonesis (Novozymes) B's current Enterprise Value is €30,275 Mil.
Novonesis (Novozymes) B's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,058 Mil.

Novonesis (Novozymes) B (WBO:NZYM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Novonesis (Novozymes) B's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	62.44	/	8.658
	=	7.21

Novonesis (Novozymes) B's share price for today is €62.44.
Novonesis (Novozymes) B's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.66.

Novonesis (Novozymes) B EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (WBO:NZYM) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines